Warning signs of alcohol-use disorder relapse – Harvard Gazette

Long-Term Recovery and Relapse in Alcohol Use Disorder: A Focus on Sustainable Development Goals

The journey to recovery for individuals with alcohol use disorder is a lifelong process, with relapse being a common challenge. Research indicates that individuals relapse an average of five times before achieving sustained sobriety, and setbacks can occur even after years of abstinence. This report highlights findings from a recent study led by John Kelly, Elizabeth R. Spallin Professor of Psychiatry at Harvard Medical School, emphasizing the importance of addressing relapse within the framework of Sustainable Development Goals (SDGs), particularly those related to health and well-being.

Study Overview and Relevance to SDGs

The study explores warning signs for relapse, especially among individuals with long periods of recovery, aligning with SDG 3: Good Health and Well-being. It addresses the chronic nature of alcohol use disorder and the need for effective disease management strategies to support sustained recovery.

Key Domains of Relapse Markers

The research identifies four primary domains influencing relapse risk:

1. Biological Factors: Changes in sleep, appetite, pain, and recreational drug use.
2. Psychological Factors: Anxiety, depression, boredom, and stress.
3. Social Factors: Loneliness, isolation, and exposure to high-risk environments or individuals.
4. Treatment and Recovery Support Changes: Alterations in medication use, attendance at support meetings, and counseling engagement.

Among these, physical pain and recreational drug use emerged as strong predictors of relapse, despite their relative rarity.

Importance of Long-Term Relapse Research

While extensive data exist on short-term relapse triggers, this study fills a critical gap by examining long-term relapse dynamics. Understanding relapse beyond the initial recovery phase is essential for developing effective interventions, which supports SDG 3 by promoting sustained health outcomes.

• Alcohol use disorder is characterized as a chronically relapsing condition, particularly within the first five years of recovery.
• Current clinical protocols lack comprehensive disease management approaches for long-term relapse prevention.
• Identifying early warning signs can enable proactive interventions, reducing morbidity and mortality associated with relapse.

Screening and Clinical Application

The study proposes a checklist tool for clinicians to monitor relapse warning signs, facilitating open communication with patients. This approach aligns with SDG 3’s target to strengthen the capacity of health systems for early detection and management of substance use disorders.

• Screening questions focus on biological, psychological, social, and treatment-related factors.
• Patients often do not recognize the gradual progression toward relapse, highlighting the need for clinician awareness and patient education.
• Effective screening can reduce stigma and encourage timely support.

Implications for Sustainable Development Goals

This research contributes to multiple SDGs by addressing the complex challenges of alcohol use disorder recovery:

• SDG 3 (Good Health and Well-being): Enhances understanding of chronic disease management and relapse prevention.
• SDG 10 (Reduced Inequalities): Supports equitable access to recovery support services and mental health care.
• SDG 17 (Partnerships for the Goals): Encourages collaboration between healthcare providers, researchers, and policymakers to implement effective relapse prevention strategies.

Key Findings and Recommendations

• Physical pain and recreational drug use are potent but under-recognized relapse risk factors.
• “California sober” approaches involving alternative substance use may increase relapse risk on primary substances.
• Cognitive vigilance and prioritizing recovery are critical to long-term sobriety.
• Early intervention can minimize social, health, and economic consequences of relapse.

Conclusion

The study underscores the necessity of integrating relapse risk monitoring into routine clinical care to support individuals in long-term recovery from alcohol use disorder. Emphasizing early detection and sustained support aligns with the Sustainable Development Goals by promoting health, reducing inequalities, and fostering partnerships for effective disease management. Continued research and implementation of these findings can enhance recovery outcomes and contribute to global health objectives.

1. Sustainable Development Goals (SDGs) Addressed or Connected to the Issues Highlighted in the Article

1. SDG 3: Good Health and Well-being
   • The article focuses on alcohol use disorder, relapse, and long-term recovery, which are directly related to health and well-being.
   • It discusses disease management, clinical interventions, and monitoring of relapse warning signs, all central to improving health outcomes.
2. SDG 10: Reduced Inequalities
   • The article touches on social factors such as loneliness, isolation, and engagement with high-risk environments, which relate to social inequalities affecting health.
   • Addressing stigma and self-shame associated with relapse also connects to reducing inequalities in access to care and social support.
3. SDG 16: Peace, Justice, and Strong Institutions
   • The emphasis on proactive clinical protocols and disease management in primary care settings aligns with strengthening institutions for better health governance.

2. Specific Targets under Those SDGs Identified Based on the Article’s Content

1. SDG 3: Good Health and Well-being
   • Target 3.5: Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.
   • Target 3.4: By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
   • Target 3.8: Achieve universal health coverage, including access to quality essential health-care services and access to safe, effective, quality, and affordable essential medicines and vaccines for all.
2. SDG 10: Reduced Inequalities
   • Target 10.2: Empower and promote the social, economic and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion or economic or other status.
3. SDG 16: Peace, Justice, and Strong Institutions
   • Target 16.6: Develop effective, accountable and transparent institutions at all levels.

3. Indicators Mentioned or Implied in the Article to Measure Progress Towards the Identified Targets

1. Indicators related to SDG 3:
   • Relapse rates among individuals with alcohol use disorder (e.g., average of five relapses before sustained sobriety).
   • Frequency and severity of warning signs such as biological (pain, sleep, appetite), psychological (anxiety, depression, stress), and social factors (loneliness, isolation).
   • Use of anti-relapse or anti-craving medication and attendance at recovery support services (meetings, counseling).
   • Number of emergency department visits or hospital stays due to relapse.
   • Self-reported psychosocial and environmental risk factors as a proxy for relapse risk.
2. Indicators related to SDG 10:
   • Levels of social isolation and engagement with high-risk environments among people in recovery.
   • Measures of stigma and self-shame associated with relapse episodes.
3. Indicators related to SDG 16:
   • Existence and implementation of clinical protocols for disease management of alcohol use disorder in primary care settings.
   • Availability and use of screening tools or checklists for early detection of relapse warning signs.

4. Table of SDGs, Targets, and Indicators

Source: news.harvard.edu